Heart Failure

Blood Pressure Paradox: Hypertension Associated with Survival in T2D and HFPatients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D PopulationFindings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.
FOURIER Clinical Outcomes Trial Results: Center Stage at ACC.17Highly anticipated, the 2-year results support the promise of PCSK9 inhibitors and also highlight important questions.
  • 1
  • 2